PDB Short entry for 1DLZ HEADER ANTIBIOTIC 13-DEC-99 1DLZ TITLE SOLUTION STRUCTURE OF THE CHANNEL-FORMER ZERVAMICIN IIB (PEPTAIBOL TITLE 2 ANTIBIOTIC) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ZERVAMICIN IIB; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: EMERICELLOPSIS SALMOSYNNEMATA; SOURCE 3 ORGANISM_TAXID: 118885 KEYWDS ZREVAMICIN, PEPTAIBOL, ANTIBACTERIAL, ANTIFUNGAL, ANTIBIOTIC, BENT KEYWDS 2 HELIX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.A.BALASHOVA,Z.O.SHENKAREV,A.A.TAGAEV,T.V.OVCHINNIKOVA,J.RAAP, AUTHOR 2 A.S.ARSENIEV REVDAT 5 27-JUL-11 1DLZ 1 REMARK REVDAT 4 13-JUL-11 1DLZ 1 VERSN REVDAT 3 24-FEB-09 1DLZ 1 VERSN REVDAT 2 26-SEP-01 1DLZ 1 HELIX REVDAT 1 03-FEB-00 1DLZ 0 JRNL AUTH T.A.BALASHOVA,Z.O.SHENKAREV,A.A.TAGAEV,T.V.OVCHINNIKOVA, JRNL AUTH 2 J.RAAP,A.S.ARSENIEV JRNL TITL NMR STRUCTURE OF THE CHANNEL-FORMER ZERVAMICIN IIB IN JRNL TITL 2 ISOTROPIC SOLVENTS. JRNL REF FEBS LETT. V. 466 333 2000 JRNL REFN ISSN 0014-5793 JRNL PMID 10682854 JRNL DOI 10.1016/S0014-5793(99)01707-X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISCOVER 3.1 REMARK 3 AUTHORS : INSIGHT II/95 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 335 NOESY PEAKS, 129 UPPER CONSTRAINTS, REMARK 3 19 ADDITIONAL LOWER CONSTRAINTS, 48 ADDITIONAL CONSTRAINTS FOR REMARK 3 HYDROGEN BONDS, 12 ANGLE CONSTRAINTS REMARK 4 REMARK 4 1DLZ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-DEC-99. REMARK 100 THE RCSB ID CODE IS RCSB010197. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303; 303 REMARK 210 PH : 5.8; 5.8 REMARK 210 IONIC STRENGTH : 0; 0 REMARK 210 PRESSURE : 1ATM; 1ATM REMARK 210 SAMPLE CONTENTS : 10MM ZERVAMICIN IIB; 3MM REMARK 210 ZERVAMICIN IIB, UNIFORM LABELING REMARK 210 WITH 15N REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; DQF-COSY; 2D TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : DYANA 1.5 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : BEST 20 OUT OF 100 WITH CA REMARK 210 BACKBONE RMSD NO LESS THAN 0.05 REMARK 210 ANGSTROMS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NOESY SPECTRUM 200MS, WE DETERMINED N15HB CONSTANT FROM REMARK 210 NOESY SPECTRA (N15 ENRICHED SAMPLE) REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ZERVAMICIN IIB IS LINEAR PEPTIDE, A MEMBER OF THE PEPTAIBOL REMARK 400 FAMILY OF MEMBRANE CHANNEL FORMING PEPTIDES. REMARK 400 HERE, ZERVAMICIN IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ZERVAMICIN IIB REMARK 400 CHAIN: A REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 0 TO 16 REMARK 400 DESCRIPTION: ZERVAMICIN IS A HEXADECAMERIC HELICAL PEPTIDE. REMARK 400 THE N-TERM IS ACETYLATED (RESIDUE 0) REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1M24 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PEPTAIBOL TRICHOTOXIN_A50E REMARK 900 RELATED ID: 1R9U RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB IN REMARK 900 METHANOL REMARK 900 RELATED ID: 1IH9 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB BOUND TO REMARK 900 DPC MICELLES REMARK 900 RELATED ID: 1GQ0 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PEPTAIBOL ANTIAMOEBIN I REMARK 900 RELATED ID: 1JOH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PEPTAIBOL ANTIAMOEBIN I REMARK 900 RELATED ID: 1AMT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PEPTAIBOL ALAMETHICIN REMARK 900 RELATED ID: 1EE7 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PEPTAIBOL CHRYSOSPERMIN C BOUND REMARK 900 TO DPC MICELLES REMARK 900 RELATED ID: 1OB7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL C REMARK 900 RELATED ID: 1OB6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL B REMARK 900 RELATED ID: 1OB4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL A DBREF 1DLZ A 0 16 NOR NOR01092 NOR01092 0 16 SEQRES 1 A 17 ACE TRP ILE GLN DIV ILE THR AIB LEU AIB HYP GLN AIB SEQRES 2 A 17 HYP AIB PRO PHL HET ACE A 0 6 HET DIV A 4 16 HET AIB A 7 13 HET AIB A 9 13 HET HYP A 10 15 HET AIB A 12 13 HET HYP A 13 15 HET AIB A 14 13 HET PHL A 16 23 HETNAM ACE ACETYL GROUP HETNAM DIV D-ISOVALINE HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID HETNAM HYP 4-HYDROXYPROLINE HETNAM PHL L-PHENYLALANINOL HETSYN HYP HYDROXYPROLINE FORMUL 1 ACE C2 H4 O FORMUL 1 DIV C5 H11 N O2 FORMUL 1 AIB 4(C4 H9 N O2) FORMUL 1 HYP 2(C5 H9 N O3) FORMUL 1 PHL C9 H13 N O HELIX 1 1 TRP A 1 HYP A 10 1 10 LINK C ACE A 0 N TRP A 1 1555 1555 1.34 LINK C GLN A 3 N DIV A 4 1555 1555 1.36 LINK C DIV A 4 N ILE A 5 1555 1555 1.36 LINK C THR A 6 N AIB A 7 1555 1555 1.35 LINK C AIB A 7 N LEU A 8 1555 1555 1.36 LINK C LEU A 8 N AIB A 9 1555 1555 1.36 LINK C AIB A 9 N HYP A 10 1555 1555 1.38 LINK C HYP A 10 N GLN A 11 1555 1555 1.35 LINK C GLN A 11 N AIB A 12 1555 1555 1.37 LINK C AIB A 12 N HYP A 13 1555 1555 1.38 LINK C HYP A 13 N AIB A 14 1555 1555 1.36 LINK C AIB A 14 N PRO A 15 1555 1555 1.37 LINK C PRO A 15 N PHL A 16 1555 1555 1.35 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000